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Abstract
Background—Tobacco smoke contains known hormonally active chemicals and reproductive 
toxicants. Several studies have examined prenatal maternal smoking and offspring age at 
menarche, but few examined earlier pubertal markers, nor accounted for exposure during 
childhood. Our objective was to examine pre- and post-natal smoke exposure in relation to timing 
of early pubertal events.
Methods—An ethnically diverse cohort of 1239 girls was enrolled at age 6–8 years for a 
longitudinal study of puberty at three U.S. sites. Girls participated in annual or semi-annual exams 
to measure anthropometry and Tanner breast and pubic hair stages. Prenatal and current tobacco 
smoke exposures, as well as covariates, were obtained from parent questionnaire. Cotinine was 
measured in urine collected at enrollment. Using accelerated failure time models, we calculated 
adjusted time ratios for age at pubertal onset (maturation stages 2 or higher) and smoke exposure.
Results—Girls with higher prenatal (≥5 cigarettes/day) or secondhand smoke exposure had 
earlier pubic hair development than unexposed (adjusted time ratio = 0.92 (95% CI 0.87–0.97) and 
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0.94 (95% CI 0.90–0.97), respectively). Including both exposures in the same model yielded 
similar associations. Higher urinary cotinine quartiles were associated with younger age at breast 
and pubic hair onset in unadjusted models, but not after adjustment.
Conclusions—Greater prenatal and childhood secondhand smoke exposure were associated 
with earlier onset of pubic hair, but not breast, development. These exposures represent modifiable 
risk factors for early pubertal development that should be considered for addition to the extensive 
list of adverse effects from tobacco smoke.
Keywords
puberty; Tanner stages; prenatal smoking; secondhand smoke; cotinine; breast development; pubic 
hair development
Introduction
The recent trend towards earlier pubertal development in girls living in developed countries 
is well-established1–4 and is of concern because of effects on later health outcomes, 
particularly breast and other reproductive system cancers.5–7 In addition, earlier age at 
puberty may lead to increased risky behaviors and adverse health effects including 
depression, anxiety, early sexual activity, substance abuse, and smoking.8–11 Increased 
awareness about concomitant rises in widespread exposure to hormonally active chemicals 
led to concerns that these exposures may be contributing to changes in pubertal 
timing.6,12–14 Further, breast cancer might result from exposures during a susceptible period 
of rapid breast growth and development.15–19 Thus, the Breast Cancer and the Environment 
Research Program (BCERP) was designed to investigate whether exposures to a variety of 
exogenous chemicals may affect the timing of puberty in girls.1,15
Tobacco smoke contains thousands of chemicals, some of which are known carcinogens, 
reproductive and developmental toxicants, or associated with hormonal changes in women, 
such as anti-estrogen and progesterone effects.20,21 Several studies have examined prenatal 
maternal smoking in relation to age at menarche, with many, but not all, showing earlier 
onset.22 In most of these studies, prenatal smoke exposure or age at menarche, or both, were 
determined retrospectively. Furthermore, menarche is a late–stage indicator of puberty. Only 
one study reported breast and pubic hair development in relation to prenatal exposure and 
also found evidence of earlier onset.23 Women who smoke during pregnancy are also likely 
to smoke postnatally, so offspring continue to be exposed. Few studies have examined 
secondhand smoke exposure in relation to age at menarche, with inconsistent results,24–27 
and none to our knowledge have examined earlier markers of pubertal transition.
Our objective was to examine pre- and postnatal smoke exposure in relation to pubertal 
timing among the BCERP cohort of over 1200 girls followed longitudinally. This is the first 
study to examine breast and pubic hair development determined by standardized exam in 
relation to multiple smoke exposure variables representing different potential windows of 
susceptibility.
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The BCERP includes a study of girls, recruited at ages 6–8 years in 2004–2007, and 
followed up to 10 years to measure onset and progression of pubertal maturation. As 
reported previously,1,2 the study was conducted using consistent methods at three sites to 
obtain a diverse sample: Kaiser Permanente in the San Francisco Bay Area (“California”), 
Cincinnati Children’s Hospital/University of Cincinnati, Ohio (“Ohio”), and Icahn School of 
Medicine at Mount Sinai, New York City (“New York”).
Eligibility criteria included no underlying endocrine-associated medical conditions (e.g., 
overt thyroid disease). The sample sources were defined as age-eligible girls in Kaiser 
Permanente area membership files at enrollment and birth , at selected schools in the greater 
Cincinnati area, and at clinics in East Harlem, NY (Black and Hispanic race/ethnicity 
only).1,2 Written informed consent was obtained from parent/guardian and child assent was 
obtained; oversight of the study was conducted by Institutional Review Boards at each site 
and the Centers for Disease Control and Prevention (CDC).
Sources of Data
In-person clinic visits, conducted annually in California and New York, and semi-annually in 
Ohio, included child anthropometry and pubertal assessment. Information on demographics, 
reproductive and child health history, and other factors potentially related to puberty was 
collected annually by standardized questionnaire from a primary caregiver (usually the 
mother). For this report, most variables analyzed were from the baseline assessment at study 
enrollment. Girl’s race/ethnicity was classified from detailed questions into mutually 
exclusive categories in the following hierarchical order: Black, Hispanic, Asian or Pacific 
Islander, and White or Other. Other potential covariates included household income, home 
ownership, maternal education and age at delivery, and daughter’s birthweight.
Pubertal maturation was determined by inspection (and palpation for breast stage) at each 
visit, and classified into breast (B1–B5) and pubic hair (PH1–PH5) Tanner stages.1 
Examiners were trained, and tested, by clinical co-investigators at each site to follow a 
written protocol, with photographs demonstrating maturation stages. Inter-rater reliability 
across sites was assessed by a master trainer with “substantial agreement” found.1 Height 
and weight were measured using calibrated scales and stadiometers. Body mass index (BMI) 
was calculated as weight/height-squared (kg/m2) and classified into percentiles using age 
and sex-specific CDC growth charts,28 with ≥85th percentile indicating overweight (and 
≥95th obesity). Clinical exam data were included in this analysis for up to 10 years (median 
7) of follow-up.
Exposure Assessment
We estimated exposure to tobacco smoke by three variables, representing different times in 
the child’s life: parent-reported maternal prenatal smoking, secondhand smoke exposure 
during the year prior to interview, and a biomarker (urine cotinine). “Prenatal exposure” is 
defined as maternal smoking during pregnancy reported on the baseline questionnaire as the 
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usual number of cigarettes and frequency smoked for each trimester. Trimester-specific 
levels were calculated as the total number of cigarettes smoked and categorized as: none, 
<400, ≥ 400. These amounts were summed and a daily average calculated over a nine-month 
duration of pregnancy, and then categorized as: none, <5/day, and ≥5/day (termed “high”).
Secondhand smoke exposure was estimated by questions on regular exposure during the past 
year; the number of smokers among household members or weekly visitors and the amount 
smoked inside the home (open-ended) were combined and categorized as: none (no smokers 
in the home, 73%), 1–35 cigarettes per week (6%), >35 cigarettes per week (7%), and a 
category for at least one smoker in the home but amount smoked was either missing or zero 
(e.g., smoked outside, 14%). If at least weekly exposure to smoke had regularly occurred 
away from home during the past year (18%), the number of hours per week was asked. An 
aggregate secondhand smoke measure was created by combining home and away, 
categorized as: none (no regular smokers at home nor regular exposure away), "high" (>35 
cigarettes per week in home, or >5 hrs/week exposed away from home and at least one 
household smoker), and low/moderate (everyone else).
We measured total cotinine in urine collected at baseline by high performance liquid 
chromatography/atmospheric pressure ionization tandem mass spectrometry (LC/MS/MS), 
using modifications of previously described methods, 29,30 in the National Center for 
Environmental Health at CDC. Briefly, urine aliquots were fortified with trideuterated 
cotinine as the internal standard, hydrolyzed overnight with β-glucuronidase, extracted with 
methylene chloride, concentrated, and injected into the LC/MS/MS. Each analytical run 
included one water blank and two quality control samples analyzed along with a set of 
calibration standards. Cotinine was quantified by comparing the peak area ratio of analyte to 
internal standard to the calibration standards using weighted least squares linear regression. 
All reported data were from runs confirmed as being in statistical control based on standard 
criteria. 31 Cotinine results were reported as nanograms per milliliter (ng/mL) with a limit of 
detection (LOD) of 0.036 ng/mL. In addition to laboratory-specific quality control 
procedures, each site included an additional 10% blinded samples drawn from the same non-
study urine sample pool; coefficients of variation from these samples were <5% across sites. 
Cotinine measurements were available for 1175 girls, of which 98% had detectable levels; 
values <LOD were imputed as LOD/√2. Cotinine levels were corrected for creatinine 
concentration and categorized into quartiles. For a subset of 215 girls in NY and CA, we had 
cotinine measurements from two additional visits. We examined within-person reliability 
over time, calculating pairwise correlation coefficients and the intra-class correlation across 
the repeated measures (spanning 3–4 years).32
Statistical analysis
Questionnaire and exam data were collected for 1239 girls; including only girls with 
cotinine measured and the smoke exposure questionnaire data yielded 1129 in primary 
survival-type analyses. Bivariate analyses of exposures by demographic variables shown to 
be potentially associated with puberty in our prior analyses or the literature was performed 
initially to identify potential confounders. Geometric mean cotinine and quartiles of log-
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transformed levels were compared across categories of demographics and self-reported 
smoking variables.
The association of each exposure with age at onset of breast or pubic hair development, 
defined as stage 2 or higher (B2+ or PH2+), was evaluated in separate accelerated failure 
time models using a Weibull distribution, with left and right censoring to account for 
pubertal transitions taking place before or after observation, and interval censoring to 
account for pubertal transitions between exam visits (Proc Lifereg, SAS v.9.3, Cary, NC). 
The time ratios compare the median age at onset among girls with the characteristic of 
interest, or the exposure, to girls in the reference category. With typical median ages of B2+ 
and PH2+ between nine and 10 years old, small time ratios can reflect large differences in 
age (e.g., 10.5y/10y = 1.05, representing a six-month lag or 5% later onset). For girls who 
reached Tanner stage 2+ during observed follow-up visits, the interval was defined as the 
period from the last exam visit consistently at stage 1 to the first visit where the girl was 
consistently at stage 2+ (i.e. no return to stage 1 in a subsequent visit). To calculate adjusted 
time ratios we included study site, annual household income, maternal education, maternal 
age at delivery, girl’s race/ethnicity, baseline BMI, and birth weight. We ran models that 
included secondhand and prenatal smoke exposures singly and together to tease apart 
associations. Too few girls had exposure only prenatally and not postnatally to examine 
separately, but we did examine the opposite (secondhand smoke, but no prenatal, exposure). 
In the later years of follow-up, girls self-reported smoking, but the few reporting any 
smoking were post-pubertal at the time and so we retained them in these analyses.
Because birthweight and BMI have been associated with prenatal smoking, they may be on 
the causal pathway to puberty, so we examined possible mediation or effect modification. 
Analytic models were run with and without BMI to assess mediation qualitatively (≥85th 
percentile vs. <85th), and in separate BMI strata or by including interaction terms with the 
smoke exposure variables to assess effect modification. A similar strategy was used to 
examine birth weight (defined as low: <5.5 lb (equivalent to <2500g), high: >9.0 lb, and 
mid: 5.5–9.0 lb). Some prior studies found differential effects of smoke exposure by race, so 
we stratified results by race/ethnicity, as well as by site, to determine their robustness. 
Sensitivity analyses were conducted excluding girls who later reported smoking (a whole 
cigarette, n=12), who had baseline urinary cotinine concentrations >50 ng/ml (n=16), who 
were pubertal at baseline (n=136–165), or who dropped out after the baseline visit (n=86).
Results
This sample of girls was racially diverse with 66% non-White, nearly one-third overweight 
at enrollment, and 10% born with low birthweight (Table 1). Over one-third of girls had 
questionnaire-reported regular secondhand smoke exposure (38%), with 8% classified as 
“high” exposure. The frequency of any exposure was highest for girls from NY (50%), with 
annual household incomes <$50,000 (53%), or whose mothers were younger at delivery 
(52%) (Table 1). Secondhand smoke exposure also varied by race; Blacks had the highest 
reported exposure (54%) and Asians the lowest (18%). As expected, regular postnatal 
exposure was more common (84%) among the girls whose mothers reported any prenatal 
smoking. Almost all the girls who had baseline cotinine levels in the lowest quartile had no 
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reported regular secondhand smoke exposure (93%), but so did 19% of girls in the highest 
quartile (Table 1).
At enrollment, about 15% of the girls had reached B2+ and 12% PH2+, and before dropping 
out or by the last follow-up exam, 89% had reached B2+ and 86% PH2+ (Table 2). As 
recently reported,2 modeled median age at B2+ in the overall cohort was lowest in Black 
participants (8.8 years), highest in White and Asian participants (each 9.7y), and mid-range 
in Hispanics (9.3y). Onset of PH2+ also varied by race, with earlier age for Blacks, but older 
for Asians, compared to Whites. Pubertal onset was earlier among girls in Ohio (for B2+), 
with higher BMI, with lower household income, or whose mothers had a younger age at 
delivery or menarche.33 In this unadjusted cross-sectional view, more than twice as many 
girls with high secondhand smoke exposure had reached puberty (B2+ or PH2+) at entry 
than non-exposed girls, and similarly for the highest versus lowest quartiles of urinary 
cotinine, but less clear by prenatal smoke exposure (Table 2).
Prenatal Smoke or Childhood Secondhand Exposure and Puberty
In longitudinal models, high prenatal smoke exposure (>5 cigarettes/day) was associated 
with earlier B2+ (Table 3), but not after adjustment (time ratio=1.02, 95%CI 0.96–1.06), and 
with earlier PH2+ onset, even after adjustment (time ratio=0.92, 95%CI 0.87–0.97). Some 
dose-response pattern was suggested with lower exposure for PH2+. The median age of 
PH2+ is ~10.2 years in the referent group; adjusted models suggest PH2+ onset 8% earlier 
(~10 months younger) among highest exposed versus unexposed. When we examined the 
trimester smoking averages separately, no specific trimester was implicated as a more 
susceptible risk period.
Similarly, highest secondhand smoke exposure was associated with earlier B2+ in the crude 
model only (time ratio=0.96, Table 3), not after adjustment (time ratio=1.0, 95% CI 0.96–
1.04). For PH2+, we found high secondhand smoke exposure associated in both crude and 
adjusted models (adjusted time ratio=0.94, 95%CI 0.90–0.97), with no association at low/
moderate exposure after adjustment. Modeling both exposures together, associations with 
PH2+ were modified only slightly; adjusted time ratio for high secondhand smoke was 0.95 
(95% CI 0.91–0.98) and for high prenatal exposure was 0.94 (95%CI 0.89–1.01) (Table 3), 
and there were no associations with B2+. Examining the subset of girls with no prenatal 
exposure, the postnatal associations were similar to overall (high secondhand smoke and 
PH2+ adjusted time ratio=0.94 (95% CI 0.90–0.98)).
The earlier PH2+ with either smoke exposure was generally consistent in additional analyses 
across race and site. An even stronger association was seen among Hispanic girls with high 
prenatal exposure (adjusted time ratio=0.78, 95% CI 0.66–0.93) (eTable 1). There was more 
variation in the B2+ associations. Some sub-groups had later B2+ with high prenatal 
exposure; e.g., CA girls (adjusted time ratio=1.16, 95%CI 1.0–1.34) and Black girls 
(adjusted time ratio=1.12, 95%CI 1.02–1.22), whereas White girls had earlier B2+ with 
either exposure (adjusted time ratio for high prenatal =0.92, 95%CI 0.84–1.0, and for high 
secondhand smoke exposure=0.91, 95%CI 0.85–0.96) (eTable 1). Stratifying by BMI 
(eTable 2), in the overweight group we found even earlier PH2+ with high exposures, 
however, there was some tendency for later B2+ with higher prenatal exposure (aTR=1.07, 
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95%CI 0.98–1.17). Interactions of BMI and secondhand smoke exposure were seen for B2+ 
(p=0.005) and PH2+ (p=0.015) and with prenatal exposure for B2+ (p=0.07). Stratifying by 
birth weight (eTable 3) confirmed the associations of earlier PH2+ with high levels of either 
smoke exposure in the mid-weight girls. However, girls with low birthweight had opposite 
patterns; e.g. later breast or pubic hair onset with higher exposures (adjusted time ratios 
1.10–1.11).
Including or removing BMI or birth weight from models did not materially change the effect 
estimates, suggesting these were not mediators of the early pubic hair development with 
higher prenatal smoke exposure association. None of the sensitivity analyses excluding 
various girls yielded materially different results.
Cotinine Levels and Puberty
For the CDC National Report on Human Exposure to Environmental Chemicals,34 cotinine 
is measured in serum. Urinary levels are typically 7–10 times higher, so using this rough 
conversion, our median level (0.52 ng/ml) was close to that of the U.S. sample of 3–11 year 
olds in 2005–06 (0.35–0.50 estimated). Geometric mean cotinine concentrations varied by 
demographic variables in the same patterns as reported secondhand smoke exposure; higher 
in girls from NY who were of lower SES, Black, or to some extent, of higher BMI (eTable 
4). Geometric mean cotinine concentrations also showed strong increasing trends with 
number of household smokers (leveling off at ≥3), total number of cigarettes smoked in the 
home weekly, smoke exposure away from home, and maternal prenatal smoking. The intra-
class correlation across repeated measures was 0.59 (95%CI 0.52–0.66), representing 
moderate to substantial agreement. 32
In unadjusted models, age at B2+ was younger with increasing cotinine quartile, with some 
dose-response pattern, as was age at PH2+ (Q4 vs Q1 time ratios=0.94 for B2+ and 0.95 for 
PH2+, Table 4). Adjustment attenuated the associations to nearly null. Sensitivity analyses, 
including deleting girls (~10%) with very low or high creatinine levels (<20 or >200 mg/
dL), yielded very similar results. Stratifying by race, Hispanic (and Asian, but based on 
small numbers) girls had earlier pubertal onset among those with cotinine concentrations in 
Q4 compared to Q1 (adjusted time ratios = 0.92, 95%CI 0.86–0.98 for B2+, and 0.95, 
95%CI 0.89–1.0 for PH2+). Adding cotinine to the model did not affect the association of 
prenatal smoke exposure and earlier PH2+.
Discussion
Our findings indicate associations between earlier pubic hair development and both prenatal 
and secondhand smoke exposure assessed by questionnaire, with robust findings across 
different sub-groups defined by race, site, or BMI, and various exclusions. These are 
consistent with prior literature on menarche; a recent meta-analysis22 reported a pooled 
effect estimate of 1 month earlier age at menarche among girls with prenatal smoke 
exposure, which was slightly stronger in birth cohorts since 1965. Prenatal smoking rates 
have greatly decreased since then, consistent with our relatively low self-reported rate, but 
nevertheless we found even greater differences (≥6 months) in age at pubic hair onset with 
higher exposure. Our data were obtained close in time to when exposure occurred (i.e., 6–8 
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years after birth) in contrast to some studies that ascertained exposure when offspring were 
adults. The meta-analysis included studies from several countries with similar findings, but 
had stronger effect estimates among Caucasians. We found some variation by race, with 
White (and to some extent Hispanic) girls showing earlier breast development, but Black 
girls later, with higher prenatal exposure. Reasons for this are unclear; there has been 
suggestion of differences in nicotine metabolism by race,35 but this seems an unlikely 
explanation given pubic hair development did not differ in the same way. Black girls have 
earlier breast development than White girls,1,3 so other un-controlled factors or genetic 
markers related to breast development might be at play.
Only one prior study of adequate size examined prenatal smoking in relation to breast and 
pubic hair staging, although based on self-assessment.23 The authors reported earlier age at 
B2+, B3+, PH3+, and menarche among offspring whose mothers smoked prenatally 
compared to those whose did not. A very small study (n=69) reported no association of 
breast development (or menarche) with prenatal smoking.36
A handful of studies examined childhood secondhand smoke exposure and age at 
menarche.24–27,37 In our prior analysis of a 1960’s birth cohort, compared to daughters of 
non-smokers, girls with the highest secondhand smoke exposures had an earlier mean age at 
menarche (almost 2 months) and girls with highest exposures to both prenatal and postnatal 
even earlier (~4 months).27 Both findings were somewhat stronger among non-Whites, 
which we did not observe in our current study. A study of a Danish birth cohort25 reported 
no association of only postnatal exposure with age at menarche, despite seeing earlier age 
with prenatal exposure. Two other very large studies26,37 that defined secondhand smoke 
exposure as living with smokers during childhood also reported earlier age at menarche, 
whereas a third, smaller study24 (n=262), reported higher risk of “late” (>12 yrs) menarche 
with secondhand (or prenatal) smoke exposure. Thus associations between secondhand 
smoke and menarche are inconsistent in the literature, perhaps because of differences in 
exposure definitions and limited separation of prenatal exposure. No prior studies examined 
secondhand smoke and earlier markers of pubertal development.
Nor have prior studies included cotinine, a specific biomarker of tobacco smoke exposure. 
While cotinine represents an exposure variable not subject to recall mis-classification, it only 
reflects recent exposure, i.e. within hours to days. If exposures are consistent over time, as 
our intra-class correlation suggested, cotinine may reflect longer term exposure, so it is not 
clear why findings differed from the self-reported exposures. One reason may be that the 
later were designed to identify more chronic, regular exposures, whereas very low-level 
secondhand smoke exposure may be difficult to avoid. Cotinine levels could represent other 
sources of nicotine not ascertained on the questionnaire, but we would not expect this to 
diminish an association. Alternatively, cotinine may not best represent the toxic chemical(s) 
in secondhand smoke that are related to pubertal onset, perhaps via a hormonal 
mechanism.38 Last, the cotinine analyses were more affected by adjustment for co-factors 
than the other smoke exposures. Perhaps one or more co-factors was related to creatinine, 
which we corrected for as recommended by the laboratory. Excluding girls with high and 
low creatinine values did not change results. Among Hispanic girls there was an association 
of higher cotinine concentrations with earlier onset of puberty.
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Our study is one of the few to examine early markers of pubertal transition in relation to 
prenatal smoke exposure and the first to examine childhood secondhand smoke exposure. 
Other strengths include assessment of puberty by clinical examination using standardized 
measures, in a large, diverse sample of pre-pubertal (mostly) girls followed prospectively. 
We collected data on a number of covariates and had good follow-up rates. There are also 
limitations, including that results may not be widely generalizable as the sample draws from 
families in urban settings who were willing to participate in a longitudinal study. Pubertal 
maturation assessments at two sites were conducted annually and thus estimates of timing of 
onset within intervals reflect some imprecision. Furthermore, self-reported prenatal smoking 
may be subject to misclassification or reporting bias, but perhaps less so in a study of 
puberty, an endpoint that has not been widely seen as a concern in relation to smoking. 
Though we controlled for some measures of SES, SES may also be related to other 
exposures affecting puberty that we did not account for, potentially resulting in residual 
confounding. Some exposures we have examined that varied by SES were associated with 
older age at pubertal onset (i.e. brominated flame retardants), so are unlikely to explain the 
smoke association.33 Another exposure, proximity to traffic, that we found associated with 
earlier pubertal onset,39 could be a potential confounder, or could reflect supportive 
evidence, as traffic-related air pollution would include some of the same chemical 
components as tobacco smoke, e.g., combustion products, metals, etc.
Puberty is a complex process leading to sexual maturation, governed by the hormonal 
milieu, yet not completely understood.4,6 There are two related processes: 1) maturation of 
the hypothalamic–pituitary–gonadal (HPG) system, or gonadarche, which affects breast 
tissue growth, and 2) maturation of the hypothalamic-pituitary-adrenal system, or 
adrenarche, more related to growth of pubic or axillary hair. Tobacco smoke contains 
hundreds of chemicals, including known reproductive toxicants and endocrine disruptors 
that could influence reproductive maturation.20 Smoking was long thought to have anti-
estrogenic effects in adult women, but also appears to affect progesterone and perhaps more 
importantly for puberty, pituitary hormones.21,40 Smoking may also effect adrenal androgen 
secretion, with increases seen in cortisol, dehydroepiandrosterone sulfate (DHEAS), DHEA 
(which increases prior to or early in puberty and is a precursor of other androgens), 
adrenaline, and catecholamine.40 Although little work has been done examining hormonal 
effects of smoke exposure in children, there is ample basis to suspect disruption of hormone-
sensitive processes. The smoke effects on adrenal hormones may be related to our finding of 
early pubic hair development, while anti-estrogenic effects to the absence of earlier breast 
development (or later in some sub-groups). Prenatal smoking is known to be associated with 
low birthweight or intra-uterine growth retardation and more recently sufficient evidence has 
accumulated to implicate obesity in offspring, potentially related to hormonal pathways as 
well.20,41 While obesity is strongly associated with age at puberty, neither it nor birthweight 
appeared to mediate the associations we observed. However, there were some indications of 
later development in exposed girls with high BMI or low birthweight, which merit further 
investigation. Lastly, age at pubertal onset has a genetic component, and genetic 
polymorphisms are involved in metabolism of smoke components, so such factors may also 
play a role.42–44
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In conclusion, this is the first study to examine the effects of several measures of tobacco 
smoke exposure on the early physical signs of pubertal onset using a longitudinal design. 
Our finding of earlier onset of pubic hair development with secondhand exposure is, to our 
knowledge, new. Results for both exposures are consistent with studies showing earlier onset 
of menarche. If associations are causal, pre- and post-natal smoke exposure represent risk 
factors for early puberty and its sequelae that are modifiable, yet exposure in the home is an 
area that is difficult to control by regulation. Early puberty potentially represents yet another 
adverse outcome associated with smoking during pregnancy or around children that could be 
added to health education messages for reducing exposure.
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Table 1









N (row %) N (row %) N (row %) N (column %)
Study Site
  New York 189 (50) 136 (36) 53 (14) 378 (33)
  Ohio 196 (58) 112 (33) 28 (8) 336 (30)
  California 315 (76) 96 (23) 4 (1) 415 (37)
Annual household income
  <$50,000 251 (47) 225 (42) 60 (11) 536 (47)
  ≥$50 – <100,000 218 (69) 77 (24) 22 (7) 317 (28)
  ≥$100,000 231 (84) 42 (15) 3 (1) 276 (24)
Maternal education
  High School or less 165 (51) 124 (39) 32 (10) 321 (29)
  Some College 166 (48) 138 (40) 39 (11) 343 (31)
  College grad or higher 365 (80) 80 (18) 12 (3) 457 (41)
Maternal age at delivery
  <25 years 146 (48) 123 (40) 37 (12) 306 (28)
  25–35 years 340 (65) 146 (28) 34 (7) 520 (48)
  >35 years 204 (77) 53 (20) 9 (3) 266 (24)
Maternal prenatal smoking
  None 685 (66) 300 (29) 50 (5) 1035 (92)
  <5 cigs/day 11 (17) 34 (53) 19 (30) 64 (6)
  ≥5 cigs/day 4 (13) 10 (33) 16 (53) 30 (3)
Child race
  Black 166 (46) 147 (41) 44 (12) 357 (32)
  Hispanic 200 (61) 107 (33) 21 (6) 328 (29)
  Asian 45 (82) 9 (16) 1 (2) 55 (5)
  White 289 (74) 81 (21) 19 (5) 389 (34)
Child BMI (at baseline)
  <85th %ile CDC 488 (64) 221 (29) 49 (6) 758 (67)
  ≥85th %ile CDC 212 (57) 123 (33) 36 (10) 371 (33)
Birth weight
  Low (<5.5 lbs) 65 (62) 33 (31) 7 (7) 105 (10)
  Mid (5.5–9.0 lbs) 560 (62) 268 (30) 71 (8) 899 (83)
  High (>9.0 lbs) 53 (73) 17 (23) 3 (4) 73 (7)
Cotinine at baseline (creatinine-adjusted)
  Q1: ≤0.25 ug/g 266 (93) 21 (7) 0 (0) 287 (25)
  Q2: 0.26–0.61 ug/g 211 (75) 68 (24) 2 (1) 281 (25)
  Q3: 0.62–2.24 ug/g 169 (61) 104 (37) 6 (2) 279 (25)
  Q4: ≥2.25 ug/g 54 (19) 151 (54) 77 (27) 282 (25)
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a
Girls with all smoke exposure variables (self-report and cotinine concentrations) non-missing, N=1129; some girls were missing data on 
characteristics.
b
SHS categories determined from combination of number of household smokers and amount smoked at home, as well as hours exposed away from 
home. No exposure reflects no regular household smokers in the home or exposure outside, High is defined as >35 cigarettes smoked per week in 
home or > 5 hrs/week SHS outside the home and at least one regular smoker at home, and Low/Moderate includes everyone else with at least some 
exposure at home or away.
BCERP indicates Breast Cancer and the Environment Research Program; BMI, body mass index; CDC, Centers for Disease Control and Prevention 
growth charts used to define overweight as BMI ≥ 85th percentile; Q1–4 indicates quartiles.
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Table 2
Proportion of Pubertal Status (Breast and Pubic Hair Development) at Study Entry and End, by Smoke 
Exposures
Exposurea At entry to study At end of study periodb
B2+ (15%) PH2+ (12%) B2+ (89%) PH2+ (86%)
Secondhand smoke
  None 89 (13%) 64 (9%) 631 (90%) 612 (87%)
  Low/Moderate 54 (16%) 48 (14%) 301 (88%) 290 (84%)
  High 23 (27%) 19 (22%) 72 (85%) 71 (84%)
Maternal prenatal smoking
  None 150 (14%) 115 (11%) 929 (90%) 899 (87%)
  <5cigs/day 12 (19%) 13 (20%) 51 (80%) 50 (78%)
  ≥5cigs/day 4 (13%) 3 (10%) 25 (83%) 25 (83%)
Child Cotininec (baseline)
  Q1: ≤0.25 ug/g 24 (8%) 23 (8%) 263 (92%) 255 (89%)
  Q2: 0.26–0.61 ug/g 40 (14%) 34 (12%) 252 (90%) 250 (89%)
  Q3: 0.62–2.24 ug/g 46 (16%) 28 (10%) 249 (89%) 235 (84%)
  Q4: ≥2.25 ug/g 56 (20%) 46 (16%) 241 (85%) 234 (83%)
a
For total N’s by category (denominators), see Table 1
b
Includes girls lost to follow-up before reaching puberty, as well as those not pubertal by last exam.
c
Urinary cotinine, corrected for creatinine
B2+ indicates onset of breast development, defined as Tanner stage 2 or higher; PH2+, onset of pubic hair development, defined as Tanner stage 2 
or higher
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